Lifeboat Foundation

Rolls-Royce Vision 100 concept car leaps into the future with an AI personal assistant and sofa for a backseat. Take a look.

Explains a lot.

Irrelevant details make it hard for seniors to trust their recall. “That extra stuff shouldn’t be in their memories at all, but it is,” says Ashley Duarte.

Wearing a specifically designed compression collar around the neck may prevent or reduce the devastating effects of head collisions in sports, two new studies have found.

The neck device, called a Q-Collar, is designed to press gently on the jugular vein to slow blood outflow increasing the brain’s blood volume, according to researchers from Cincinnati Children’s Hospital Medical Centre in the US.

The resulting effect of the increased blood volume helps the brain fit tighter within the skull cavity, reducing the energy absorbed by the brain during collisions, researchers said.

Continue reading “New neck collar may protect players from brain injuries” »

WEDNESDAY, June 15, 2016 (HealthDay News) — Brain cancer patients might benefit from an implantable ultrasound device that appears to enhance chemotherapy treatment, a small study says.

Researchers from the Pitie-Salpetriere Hospital in Paris and other French institutions tested the experimental device on 15 patients with recurrent glioblastoma, a particularly deadly brain cancer. When the so-called SonoCloud was activated, sound waves opened the blood-brain barrier, letting in more chemotherapy, they said.

“The walls of the blood vessels in the brain are very difficult to cross for certain molecules,” said Frederic Sottilini, CEO of Paris-based CarThera, the company developing SonoCloud.

Continue reading “Novel Brain Cancer Treatment Taps Into Sound Waves” »

How Foundation Medicine is creating shareholder value.

Awesome!

University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate identification of molecules, the team will quantitate the amount of anti-cancer drugs present in individual cancer cells, including those in bladder cancer cells isolated from patients undergoing chemotherapy. The method will provide a means to establish ideal dosing regimens that delivers effective chemotherapeutic concentrations to patients with minimal toxicities.

Anthony Burgett and Zhibo Yang, assistant professors in the Department of Chemistry and Biochemistry in the OU College of Arts and Sciences, and affiliates of the Stephenson Cancer Center, in collaboration with Jonathan E. Heinlen, M.D., assistant professor in the Department of Urology at the OU Health Sciences Center and a Stephenson Cancer Center researcher, will fully develop the novel first-in-class mass spectrometric technology—the Single Probe—capable of performing single-cell mass spectrometry of compounds inside of living single cancer cells as a bioanalytical method to improve efficacy and toxicities of chemotherapy in patients.

Continue reading “New analytical technology could improve cancer treatment” »

Technology invented in the Bay Area could help keep American astronauts safe from dangerous microbes on far away missions like a journey to Mars. (KGO-TV)

I told many people that this was coming a few years ago; so glad. Wait until you see smart meds that people can never become addicted or overdose on because the smart med reads your system and knows when enough is enough.

The security solutions company uses botanical-DNA based tools to tag, track, and trace products for an array of industries. Now with the hire of a personal care supply chain management expert, the company is set to expand its engagement with the industry.

This week the Stony Brook, New York–based company announced that Barbara Brockway has accepted the role of Director of Personal Care.

Continue reading “Applied DNA Sciences to grow its cosmetics, fragrances, and personal care business” »

Nice.

Renowned physicist, author and broadcaster, Professor Jim Al-Khalili OBE, has been awarded the inaugural Stephen Hawking Medal for Science Communication.

Professor Jim Al-Khalili is the first person to be honoured for his contribution to science with this, first medal of its kind, at STARMUS International Science and Arts Festival in Tenerife on 29 June 2016.

Continue reading “University of Surrey Professor and BBC presenter receives Stephen Hawking Medal” »